Journal article · 2024

A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy

Mengyu Chang, Man Wang, Bin Liu, Wenbin Zhong, Deblin Jana, Yifan Wang, Shiyan Dong, Abin Antony, Chunxia Li, Yuhui Liu, Zhongqi Zhao, Jun Lin and 2 more

ACS Nano, 18(11), 8143–8156 · Published 4 March 2024 · DOI 10.1021/acsnano.3c11960

View at the publisherCite this paper

In brief

“A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy” is a 2024 journal article by Mengyu Chang and 13 co-authors, published in ACS Nano. OpenAlex counts 41 citations as of 21 November 2026, which puts it in the top 3% of works published in 2024 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
41
Most cited in
2026 (21)
Field-weighted impact
3.45
References
61
Authors
14

Abstract

The complexity and heterogeneity of individual tumors have hindered the efficacy of existing therapeutic cancer vaccines, sparking intensive interest in the development of more effective in situ vaccines. Herein, we introduce a cancer nanovaccine for reactive oxygen species-augmented metalloimmunotherapy in which FeAl-layered double hydroxide (LDH) is used as a delivery vehicle with dihydroartemisinin (DHA) as… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Chang, M., Wang, M., Liu, B., Zhong, W., Jana, D., Wang, Y., Dong, S., Antony, A., Li, C., Liu, Y., Zhao, Z., Lin, J., Jiang, W., & Zhao, Y. (2024). A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy. ACS Nano, 18(11), 8143–8156. https://doi.org/10.1021/acsnano.3c11960

MLA 9

Chang, Mengyu, et al. “A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy.” ACS Nano, vol. 18, no. 11, 2024, pp. 8143–8156. https://doi.org/10.1021/acsnano.3c11960.

Chicago

Chang, Mengyu, Man Wang, Bin Liu, Wenbin Zhong, Deblin Jana, Yifan Wang, Shiyan Dong, et al. 2024. “A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy.” ACS Nano 18 (11): 8143–8156. https://doi.org/10.1021/acsnano.3c11960.

Harvard

Chang, M. et al. (2024) ‘A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy’, ACS Nano, 18(11), pp. 8143–8156. doi:10.1021/acsnano.3c11960.

IEEE

M. Chang et al., “A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy,” ACS Nano, vol. 18, no. 11, pp. 8143–8156, 2024, doi: 10.1021/acsnano.3c11960.

BibTeX

@article{chang2024cancer,
  title     = {{A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy}},
  author    = {Chang, Mengyu and Wang, Man and Liu, Bin and Zhong, Wenbin and Jana, Deblin and Wang, Yifan and Dong, Shiyan and Antony, Abin and Li, Chunxia and Liu, Yuhui and Zhao, Zhongqi and Lin, Jun and Jiang, Wen and Zhao, Yanli},
  journal   = {ACS Nano},
  year      = {2024},
  volume    = {18},
  number    = {11},
  pages     = {8143--8156},
  doi       = {10.1021/acsnano.3c11960},
  url       = {https://doi.org/10.1021/acsnano.3c11960}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202466
20251414
20262121

Its field-weighted citation impact is 3.45: it has been cited 3.45 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics

  • cancer nanovaccine
  • dihydroartemisinin
  • reactive oxygen species
  • Fenton reaction
  • ferroptosis
  • immunogenic cell death
  • tumor-associated antigens
  • alum adjuvant

Work with this paper

Most-cited papers in Engineering

All highly cited Engineering papers

Questions about this paper

How do I cite this paper in APA style?

Chang, M., Wang, M., Liu, B., Zhong, W., Jana, D., Wang, Y., Dong, S., Antony, A., Li, C., Liu, Y., Zhao, Z., Lin, J., Jiang, W., & Zhao, Y. (2024). A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy. ACS Nano, 18(11), 8143–8156. https://doi.org/10.1021/acsnano.3c11960

How many times has this paper been cited?

41 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Mengyu Chang, Man Wang, Bin Liu, Wenbin Zhong, Deblin Jana, Yifan Wang, Shiyan Dong, Abin Antony, Chunxia Li, Yuhui Liu, Zhongqi Zhao, Jun Lin and 2 more.

What is the DOI of this paper?

10.1021/acsnano.3c11960, permanently at https://doi.org/10.1021/acsnano.3c11960. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.